OncoMatch

OncoMatch/Clinical Trials/NCT04290663

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Is NCT04290663 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies Systematic RAI-treatment for thyroid cancer.

Phase 3RecruitingCentre Francois BaclesseNCT04290663Data as of May 2026

Treatment: Systematic RAI-treatmentThis trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

Check if I qualify

Extracted eligibility criteria

Cancer type

Thyroid Cancer

Disease stage

Excluded: Stage PT1A, PT3, PT4, PT1AN0/X, PT1BN0/X, PT2N0/NX, PT1AN1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION <2MM, PT1BN1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION <2MM, PT2N1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION <2MM, PT1AN1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION >10MM, PT1BN1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION >10MM, PT2N1 WITHOUT EXTRA-THYROID EXTENSION AND WITH NODAL LARGEST DIMENSION >10MM, PT2N0/NX WITHOUT EXTRA-THYROID EXTENSION, PT3B

T1b or T2 with minimal extra-thyroid extension into the perithyroidal soft tissues and/or pN1 with largest nodal dimension between 2 and 10 mm, without extra-capsular invasion and with a number of metastatic nodes ≤ 10 T1aN1 with largest nodal dimension between 2 and 10 mm, without extra-capsular invasion and with a number of metastatic nodes ≤ 10

Performance status

ECOG 0–1(Restricted strenuous activity)

Prior therapy

Must have received: total thyroidectomy

Patient treated by total thyroidectomy with macroscopically complete tumor resection (R0 or R1) ± neck dissection

Must have received: LT4 treatment

Post-operative LT4 treatment initiated at least 6 weeks before randomization

Cannot have received: lobectomy only

Patients who have undergone lobectomy only

Cannot have received: previous RAI treatment for thyroid cancer

Previous RAI treatment for thyroid cancer

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify